Democratizing Access to Cleaner Residential Air
ConditionCardiovascular (CV) Risk
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorDouglas Brugge
About this trial
The purpose of this research study is to determine whether the use of in-home air filtration to reduce exposure to air pollution benefits health.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Crossover
Treatments tested in this trial
Portable air purifiers with HEPA filtration
Other interventionPortable air purifiers filter air and reduce exposure to air pollutants, in this case, airborne particulate matter
Portable air purifiers without filtration (sham)
Other interventionAir purifiers with filters removed (sham)
Treatment groups
66 Participants
are divided into 2 treatment groupsGroup A: Active filtrationExperimental treatment 1 intervention
Group B: Sham filtrationSham comparator 1 intervention
Trial outcomes
Primary outcomes
1
Blood pressure
Periferal blood pressure, seated
Time frame
Day 0, 30, 45, and 75Secondary outcomes
1
IL-1beta
Blood inflammatory biomarker
Time frame
Day 0, 30, 45, and 75Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Douglas Brugge
Lead sponsor
UConn Health
Sponsor institution
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: